Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis

[1]  H. Ueda,et al.  Involvement of lysophosphatidic acid–induced astrocyte activation underlying the maintenance of partial sciatic nerve injury–induced neuropathic pain , 2018, Pain.

[2]  松岡 峰造.  Neurotropin® Accelerates the Differentiation of Schwann Cells and Remyelination in a Rat Lysophosphatidylcholine-Induced Demyelination Model , 2018 .

[3]  H. Yoshikawa,et al.  Neurotropin® Accelerates the Differentiation of Schwann Cells and Remyelination in a Rat Lysophosphatidylcholine-Induced Demyelination Model , 2018, International journal of molecular sciences.

[4]  N. Stergiopulos,et al.  Role of ERK1/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine. , 2017, Atherosclerosis.

[5]  H. Ueda.  Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain. , 2017, Pain.

[6]  N. Lago,et al.  Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury , 2015, The Journal of Neuroscience.

[7]  K. Ishibashi,et al.  Expression and Function of LPA1 in Bladder Cancer. , 2015, The Journal of urology.

[8]  H. Daida,et al.  Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Montaner,et al.  Lysophosphatidylcholine to stratify risk of ischemic stroke in TIA , 2015, Neurology.

[10]  M. Portero-Otín,et al.  Metabolomics predicts stroke recurrence after transient ischemic attack , 2015, Neurology.

[11]  J. Aoki,et al.  Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS , 2014, Journal of Lipid Research.

[12]  G. Prestwich,et al.  Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. , 2013, American journal of respiratory and critical care medicine.

[13]  Lin Ma,et al.  An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model , 2013, Molecular pain.

[14]  N. V. Prokazova,et al.  Effect of Lysophosphatidylcholine on α-Adrenoreactivity of Rat Aorta Smooth Muscles , 2011, Bulletin of Experimental Biology and Medicine.

[15]  W. Moolenaar,et al.  Autotaxin and LPA receptor signaling in cancer , 2011, Cancer and Metastasis Reviews.

[16]  Constantin Schizas,et al.  Qualitative Grading of Severity of Lumbar Spinal Stenosis Based on the Morphology of the Dural Sac on Magnetic Resonance Images , 2010, Spine.

[17]  Kozo Nakamura,et al.  Predictors of residual symptoms in lower extremities after decompression surgery on lumbar spinal stenosis , 2010, European Spine Journal.

[18]  H. Ueda,et al.  Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine , 2010, Molecular pain.

[19]  M. Kurokawa,et al.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma , 2008, British journal of haematology.

[20]  R. Abel,et al.  Gait analysis does not correlate with clinical and MR imaging parameters in patients with symptomatic lumbar spinal stenosis , 2008, BMC musculoskeletal disorders.

[21]  M. Tezer,et al.  Degenerative lumbar spinal stenosis: correlation with Oswestry Disability Index and MR Imaging , 2008, European Spine Journal.

[22]  M. Nangaku,et al.  Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[23]  Kazuhiro Nakamura,et al.  Both Plasma Lysophosphatidic Acid and Serum Autotaxin Levels are Increased in Chronic Hepatitis C , 2007, Journal of clinical gastroenterology.

[24]  H. Yoshikawa,et al.  Surgical Outcome of Drop Foot Caused by Degenerative Lumbar Diseases , 2007, Spine.

[25]  C. Wessig,et al.  In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging , 2007, Experimental Neurology.

[26]  S. Georas,et al.  Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[28]  A. Haig,et al.  Electromyographic and magnetic resonance imaging to predict lumbar stenosis, low-back pain, and no back symptoms. , 2007, The Journal of bone and joint surgery. American volume.

[29]  K. Tallroth,et al.  Comparison of Radiologic Signs and Clinical Symptoms of Spinal Stenosis , 2006, Spine.

[30]  H. Ueda,et al.  Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling , 2004, Nature Medicine.

[31]  Jacques Fermanian,et al.  Development and validation of the Neuropathic Pain Symptom Inventory , 2004, Pain.

[32]  J. Weinstein,et al.  Predictors of surgical outcome in degenerative lumbar spinal stenosis. , 1999, Spine.

[33]  R. Porter,et al.  Spinal stenosis and neurogenic claudication. , 1996, Spine.

[34]  M. Liang,et al.  Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. , 1995, Journal of clinical epidemiology.

[35]  J. Weinstein,et al.  Clinical Correlates of Patient Satisfaction After Laminectomy for Degenerative Lumbar Spinal Stenosis , 1995, Spine.

[36]  U. Beuers,et al.  Lysophosphatidic acid and signaling in sensory neurons. , 2015, Biochimica et biophysica acta.